期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

胶乳增强免疫比浊法定量测试血清肌钙蛋白在日立7180全自动生化仪上的应用评价 被引量：4

暂未订购
导出
摘要 目的探讨胶乳增强免疫比浊法定量测试血清肌钙蛋白Ⅰ(cTnⅠ)在日立7180全自动生化分析仪的应用性能评价。方法系统研究胶乳增强免疫比浊法测定cTnⅠ灵敏度、精密度及干扰因素。结果胶乳增强免疫比浊法测定cTnⅠ批内平均变异系数(CV)为1.66%,批间平均CV为4.0%.平均回收率102%。血红蛋白在2.5 g/L以下对测定结果无干扰,三酰甘油4.5 ng/mL以下对测定结果无干扰,类风湿因子小于120 U/L,测定结果无干扰,胆红素无干扰,与奥林巴斯全自动生化仪用胶乳增强免疫比浊法测定cTnⅠ比较有良好的相关性Y=1.008 9X+0.002 5,r=0.9950(P<0.01)。结论胶乳增强免疫比浊法定量测定cTnⅠ方法简便、快速,具有较高的灵敏度和精密度,可用于全自动分析仪测试,适用于大批量及临床常规使用。
作者 李小玲 练小芬
机构地区 广东新兴县人民医院检验科
出处 《检验医学与临床》 CAS 2011年第8期993-994,共2页 Laboratory Medicine and Clinic
关键词 乳胶增强免疫比浊 肌钙蛋白Ⅰ 心肌损伤 性能评价.
分类号 R541 [医药卫生—心血管疾病]
  • 相关文献

参考文献3

  • 1潘柏申.心肌肌钙蛋白的临床应用和检测进展[J].上海医学检验杂志,2003,18(1):6-8. 被引量：28
  • 2Kartrukha AG,Bereznikova AV,Esakova TV,et al.Troponin I is released in blood st ream of pat ients with acutemyocardial infarctionnot in free form but as complex[J].Clin Chem,1997,43(8):1379-1385.
  • 3Eugene B,Raymond J,Elliott M,et al.ACC/AHA 2002 guidline update for the management of patients with unstableangina and non-ST-segment elevation myocardial infarction[J].J Coll Cardiol,2002,40(7):1366-1374.

二级参考文献11

  • 1田吉明,丁树哲.运动性骨骼肌损伤标志的研究进展[J].浙江体育科学,2001,23(1):52-54. 被引量：31
  • 2Panteghini M. IFCC Committee on Standardization of Markers of Cardiac Damage: premises and project presentation[J]. Clin Chem Lab Med, 1998,36: 887-893.
  • 3Panteghini M, Apple FS, Christenson RH, et al. Proposal from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD) : Recommendation on use of biochemical markers of cardiac damage in acute coronary syndromes[J]. Scan J Clin Lab Invest, 1999,59 : 103-112.
  • 4Dati F, Panteghini M, Apple FS, et al. Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage ( C-SMCD ) : Strategies and concepts on standardization of cardiac marker assyas[J]. Scand J Clin Lab Invest, 1999,59:113-123.
  • 5Panteghini M, Apple FS, Christenson RH, et al. Use of biochemical markers in acute coronary syndromes.IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage[J]. Clin Chem Lab Med, 1999,37:687-693.
  • 6Panteghini M, Gerhardt W, Apple FS, et al. Quality specifications for cardiac troponin assays. International Federation of Clinical Chemistry and Laboratory Medicine(IFCC). IFCC Scientific Division Committee on Standardization of Markers of Cardiac Damage[ J ].Clin Chem Lab Med, 2001,39:174-178.
  • 7Wu AHB, Apple FS, Gibler WB, et al. National Academy of Clinical Biochemistry standards of laboratory practice: Recommendations for the use of cardiac markers in coronary artery diseases [J ]. Clin Chem,1999,45 : 1104-1121.
  • 8The Joint European Society of Cardiology/American College Cardiology Committee. Myocardial infarction redefined-A consensus document of the Joint European Society of Cardiology/American College Cardiology Committee for the redefinition of myocardial infarction[S]. J Am Coll Cardial, 2000,36-959-969.
  • 9Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA Guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations[J]. Circulation, 2000,102:1193-1209.
  • 10Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 Guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction [ DB/OL ]. http://www.acc. org/clinical/guidelines/unst able/incorporated/UA_incorporated, 2002-10-17.

共引文献27

同被引文献42

引证文献4

二级引证文献14

检验医学与临床
2011年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部